■ Nicardipene
■ Calcium channel blocker
■ ↓Peripheral vascular resistance
■ ↓Cerebral vasospasm (good for stroke syndromes)
■ Nitroglycerin
■ Venous >>arteriolar dilation
■ Labetalol
■ α 1 -,β-Adrenergic blocker
■ Much more β-blockade than α-blockade
■ Effective as single agent
■ Esmolol
■ β 1 -Adrenergic blocker
■ Very short acting
■ Often used with nitroprusside to blunt tachycardia
■ Hydralazine
■ Direct arteriolar vasodilator (watch for reflex tachycardia)
■ Phentolamine
■ Pureα-blocker
CARDIOVASCULAR TESTING
The following summary briefly reviews some of the common modalities used
to further delineate primary cardiovascular disorders. It is not a comprehen-
sive source but rather covers key points pertinent to the ED physician’s man-
agement of patients with cardiovascular diseases.
ECHOCARDIOGRAM
■ Transthoracic echo (TTE)
■ Evaluates ventricular size and function
■ Identifies valvular pathology
■ Detects effusions and tamponade physiology
■ Stress echo identifies areas of hypokinesis, akinesis, or dyskinesis during
exercise or pharmacologic stress tests.
■ Transesophageal echo (TEE)
■ Due to placement in the esophagus, more detailed studies can be
obtained.
■ Identifies mural thrombi prior to cardioversion
■ Higher sensitivity than TTE in detecting aortic dissection
■ More invasive and technically more difficult than TTE
HOLTERMONITORING
■ Ambulatory ECG monitor that records dysrhythmias and other pathologies
■ Correlated with patient’s diary of symptoms
■ An event recorder allows the patient to activate the recorder at the onset of
symptoms.
TILT-TABLETESTING
■ Used to evaluate patients with suspected vasovagal syncope
■ Goal is to provoke syncope while patient is monitored.
■ As table tilts, blood pools in LE venous system.
■ Venous return ↓
■ Myocardial contraction to compensate
↓
CARDIOVASCULAR EMERGENCIES